bf/NASDAQ:ANIK_icon.jpeg

NASDAQ:ANIK

Anika Therapeutics

  • Stock

USD

Last Close

9.75

06/11 21:01

Market Cap

389.26M

Beta: 0.83

Volume Today

45.35K

Avg: 81.01K

PE Ratio

−14.02

PFCF: −31.16

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
11.70M
-
13.67M
16.84%
15.46M
13.08%
19.01M
22.95%
21.67M
13.99%
21.65M
0.09%
34.10M
57.53%
41.11M
20.55%
37.89M
7.84%
43.08M
13.69%
average payables
2.00M
-
4.75M
137.87%
5.30M
11.59%
4.53M
14.66%
4.95M
9.28%
3.49M
29.47%
6.41M
83.74%
8.31M
29.66%
8.35M
0.54%
9.47M
13.33%
average receivables
17.94M
-
19.40M
8.12%
24.63M
26.92%
25.71M
4.41%
22.30M
13.27%
21.93M
1.67%
23.59M
7.59%
26.97M
14.34%
32.23M
19.51%
35.29M
9.49%
book value per share
12.13
-
14.12
16.36%
15.17
7.47%
18.08
19.15%
18.25
0.97%
20.42
11.88%
19.15
6.21%
19.94
4.08%
19.61
1.62%
14.48
26.15%
capex per share
-0.11
-
-0.62
483.87%
-0.95
54.52%
-0.62
35.45%
-0.32
47.67%
-0.20
37.90%
-0.11
42.82%
-0.36
211.98%
-0.51
43.96%
-0.37
27.97%
capex to depreciation
-0.33
-
-2.44
640.48%
-3.75
53.58%
-2.09
44.23%
-0.79
62.36%
-0.47
40.10%
-0.12
74.38%
-0.36
197.09%
-0.52
43.85%
-0.38
26.22%
capex to operating cash flow
-0.04
-
-0.24
507.95%
-0.59
149.33%
-0.22
62.63%
-0.13
39.40%
-0.08
42.71%
-0.12
63.11%
-0.61
391.53%
-1.70
177.22%
3.04
278.77%
capex to revenue
-0.01
-
-0.10
574.50%
-0.14
36.66%
-0.08
41.59%
-0.04
44.29%
-0.02
44.08%
-0.01
49.41%
-0.03
178.85%
-0.05
37.69%
-0.03
32.04%
cash per share
7.28
-
9.27
27.30%
8.50
8.35%
10.79
26.97%
11.01
2.05%
13.10
18.95%
6.91
47.22%
6.55
5.19%
5.93
9.54%
4.97
16.14%
days of inventory on hand
216.36
-
258.98
19.70%
242.80
6.25%
293.92
21.05%
248.55
15.44%
279.27
12.36%
274.56
1.69%
202.67
26.18%
231.63
14.29%
266.32
14.97%
days payables outstanding
20.95
-
143.93
587.10%
34.99
75.69%
90.00
157.24%
36.68
59.25%
48.65
32.66%
53.38
9.71%
42.96
19.52%
52.86
23.04%
56.61
7.10%
days sales outstanding
59.29
-
84.98
43.33%
97.44
14.66%
76.67
21.31%
71.84
6.30%
73.50
2.31%
67.43
8.25%
73.70
9.29%
80.90
9.76%
78.76
2.64%
debt to assets
-0.00
-
-0.00
28.63%
0.07
-
0.06
9.72%
0.06
1.87%
0.09
46.75%
0.11
21.27%
debt to equity
-0.00
-
-0.00
31.17%
0.08
-
0.08
5.66%
0.07
11.49%
0.11
48.20%
0.14
26.46%
dividend yield
earnings yield
0.06
-
0.05
15.77%
0.05
16.11%
0.04
10.57%
0.04
4.74%
0.04
3.71%
-0.04
200.32%
0.01
121.50%
-0.03
530.30%
-0.25
622.02%
enterprise value
497.84M
-
459.17M
7.77%
614.57M
33.84%
652.48M
6.17%
396.35M
39.25%
596.08M
50.39%
568.75M
4.58%
440.84M
22.49%
375.57M
14.81%
288.27M
23.24%
enterprise value over ebitda
8.10
-
9.54
17.74%
12.14
27.30%
14.27
17.49%
18.22
27.72%
17.40
4.50%
-926.30
5,422.12%
-11.14
98.80%
-19.36
73.79%
-25.70
32.78%
ev to operating cash flow
12.45
-
11.75
5.61%
25.82
119.67%
15.99
38.08%
11.35
29.00%
16.11
41.91%
43.53
170.25%
52.50
20.60%
85.18
62.25%
-161.23
289.27%
ev to sales
4.71
-
4.94
4.73%
5.94
20.40%
5.75
3.23%
3.75
34.73%
5.20
38.51%
4.36
16.18%
2.98
31.58%
2.40
19.41%
1.73
28.04%
free cash flow per share
2.62
-
2.00
23.68%
0.67
66.64%
2.18
227.64%
2.10
4.06%
2.42
15.51%
0.80
66.77%
0.23
71.90%
-0.21
193.52%
-0.49
132.96%
free cash flow yield
0.06
-
0.05
18.52%
0.01
74.00%
0.04
197.55%
0.06
53.89%
0.05
25.13%
0.02
61.94%
0.01
64.51%
-0.01
213.21%
-0.02
204.31%
graham net net
7.50
-
9.19
22.57%
9.26
0.76%
11.46
23.73%
11.76
2.64%
12.10
2.91%
3.26
73.11%
5.16
58.55%
4.71
8.70%
4.41
6.37%
graham number
26.70
-
25.58
4.19%
27.51
7.55%
29.80
8.32%
23.07
22.57%
29.75
28.92%
26.96
9.38%
11.35
57.91%
21.22
87.01%
42.87
102.04%
income quality
1.04
-
1.27
21.73%
0.73
42.42%
1.28
75.41%
1.87
45.40%
1.36
27.04%
-0.54
140.03%
2.03
472.85%
-0.30
114.61%
0.02
107.29%
intangibles to total assets
0.12
-
0.08
32.22%
0.07
10.57%
0.07
8.11%
0.06
8.43%
0.05
24.37%
0.27
489.48%
0.26
4.74%
0.23
9.54%
0.03
88.08%
interest coverage
-1.06K
-
-401.12
62.05%
-192.42
52.03%
-96.68
49.76%
-14.92
84.57%
47.91
-
98.30
105.18%
-29.66
130.18%
-11.01
62.89%
interest debt per share
-0.00
-
-0.01
214.45%
-0.02
70.07%
-0.03
53.21%
-0.10
211.08%
1.59
1,678.85%
1.56
2.24%
1.44
7.46%
2.17
50.23%
2.14
1.26%
inventory turnover
1.69
-
1.41
16.46%
1.50
6.66%
1.24
17.39%
1.47
18.26%
1.31
11.00%
1.33
1.72%
1.80
35.47%
1.58
12.50%
1.37
13.02%
invested capital
-0.00
-
-0.00
31.17%
0.08
-
0.08
5.66%
0.07
11.49%
0.11
48.20%
0.14
26.46%
market cap
597.99M
-
569.88M
4.70%
718.83M
26.14%
785.74M
9.31%
485.40M
38.22%
732.17M
50.84%
643.69M
12.09%
515.99M
19.84%
431.01M
16.47%
332.10M
22.95%
net current asset value
123.13M
-
151.53M
23.07%
152.97M
0.95%
187.20M
22.38%
187.56M
0.19%
193.41M
3.12%
84.18M
56.48%
108.08M
28.39%
105.98M
1.94%
104.94M
0.98%
net debt to ebitda
-1.63
-
-2.30
41.11%
-2.06
10.42%
-2.91
41.44%
-4.09
40.49%
-3.97
2.94%
122.05
3,171.31%
1.90
98.44%
2.86
50.49%
3.91
36.76%
net income per share
2.61
-
2.06
21.11%
2.22
7.63%
2.18
1.53%
1.30
40.61%
1.93
48.55%
-1.69
187.57%
0.29
117.02%
-1.02
455.48%
-5.64
452.74%
operating cash flow per share
2.72
-
2.62
3.96%
1.62
38.03%
2.80
72.73%
2.42
13.65%
2.62
8.39%
0.92
64.94%
0.58
36.53%
0.30
48.07%
-0.12
140.29%
payables turnover
17.42
-
2.54
85.45%
10.43
311.41%
4.06
61.13%
9.95
145.39%
7.50
24.62%
6.84
8.85%
8.50
24.25%
6.91
18.72%
6.45
6.63%
receivables turnover
6.16
-
4.30
30.23%
3.75
12.79%
4.76
27.09%
5.08
6.73%
4.97
2.26%
5.41
9.00%
4.95
8.50%
4.51
8.89%
4.63
2.72%
research and ddevelopement to revenue
0.08
-
0.10
25.29%
0.10
7.43%
0.17
59.56%
0.17
4.04%
0.15
15.62%
0.18
23.52%
0.18
2.95%
0.18
2.44%
0.20
8.74%
return on tangible assets
0.22
-
0.14
36.72%
0.15
2.87%
0.12
17.43%
0.07
40.75%
0.09
20.62%
-0.09
204.57%
0.02
117.82%
-0.06
446.23%
-0.31
465.08%
revenue per share
7.19
-
6.23
13.44%
7.04
13.07%
7.78
10.52%
7.31
6.08%
8.12
11.05%
9.17
13.02%
10.26
11.88%
10.73
4.55%
11.37
5.98%
roe
0.22
-
0.15
32.20%
0.15
0.15%
0.12
17.35%
0.07
41.18%
0.09
32.77%
-0.09
193.36%
0.01
116.36%
-0.05
461.35%
-0.39
648.46%
roic
0.21
-
0.15
32.28%
0.15
0.13%
0.12
17.79%
0.07
44.31%
0.08
16.59%
-0.04
149.47%
-0.10
150.53%
-0.04
53.69%
-0.09
106.41%
sales general and administrative to revenue
0.14
-
0.16
11.67%
0.17
9.30%
0.19
8.99%
0.33
71.28%
shareholders equity per share
12.13
-
14.12
16.36%
15.17
7.47%
18.08
19.15%
18.25
0.97%
20.42
11.88%
19.15
6.21%
19.94
4.08%
19.61
1.62%
14.48
26.15%
stock based compensation to revenue
0.02
-
0.02
57.17%
0.03
37.14%
0.05
56.04%
0.10
104.39%
0.05
49.25%
0.04
22.26%
0.08
81.67%
0.09
22.16%
0.09
0.18%
tangible asset value
154.86M
-
191.71M
23.79%
205.33M
7.11%
244.64M
19.14%
246.57M
0.79%
273.10M
10.76%
172.83M
36.72%
196.92M
13.94%
203.63M
3.40%
204.69M
0.52%
tangible book value per share
10.55
-
12.84
21.67%
13.99
8.94%
16.78
20.02%
17.07
1.72%
19.34
13.28%
12.15
37.16%
13.67
12.52%
13.98
2.27%
13.65
2.38%
working capital
133.05M
-
159.16M
19.62%
161.64M
1.56%
193.25M
19.56%
191.65M
0.83%
219.47M
14.51%
140.52M
35.97%
138.73M
1.27%
141.63M
2.09%
132.25M
6.62%

All numbers in USD (except ratios and percentages)